Pko Investment Management Joint Stock CO Biomarin Pharmaceutical Inc Transaction History
Pko Investment Management Joint Stock CO
- $882 Billion
- Q1 2025
A detailed history of Pko Investment Management Joint Stock CO transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 9,000 shares of BMRN stock, worth $495,000. This represents 0.07% of its overall portfolio holdings.
Number of Shares
9,000
Previous 12,000
25.0%
Holding current value
$495,000
Previous $789 Million
19.34%
% of portfolio
0.07%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$978 Million1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$823 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$594 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...